Abstract:Our skin protects us from external threats including ultraviolet radiation, pathogens and chemicals, and prevents excessive trans-epidermal water loss. These varied activities are reliant on a vast array of lipids, many of which are unique to skin, and that support physical, microbiological and immunological barriers. The cutaneous physical barrier is dependent on a specific lipid matrix that surrounds terminally-differentiated keratinocytes in the stratum corneum . Sebum- and keratinocyte-derived lipids cover the skin's surface and support and regulate the skin microbiota. Meanwhile, lipids signal between resident and infiltrating cutaneous immune cells, driving inflammation and its resolution in response to pathogens and other threats. Lipids of particular importance include ceramides, which are crucial for stratum corneum lipid matrix formation and therefore physical barrier functionality, fatty acids, which contribute to the acidic pH of the skin surface and regulate the microbiota, as well as the stratum corneum lipid matrix, and bioactive metabolites of these fatty acids, involved in cell signalling, inflammation, and numerous other cutaneous processes. These diverse and complex lipids maintain homeostasis in healthy skin, and are implicated in many cutaneous diseases, as well as unrelated systemic conditions with skin manifestations, and processes such as ageing. Lipids also contribute to the gut-skin axis, signalling between the two barrier sites. Therefore, skin lipids provide a valuable resource for exploration of healthy cutaneous processes, local and systemic disease development and progression, and accessible biomarker discovery for systemic disease, as well as an opportunity to fully understand the relationship between the host and the skin microbiota. Investigation of skin lipids could provide diagnostic and prognostic biomarkers, and help identify new targets for interventions. Development and improvement of existing in vitro and in silico approaches to explore the cutaneous lipidome, as well as advances in skin lipidomics technologies, will facilitate ongoing progress in skin lipid research.

Topographical variations in the skin barrier and their role in disease pathogenesis

Research progress of skin barrier defects in atopic dermatitis

The skin microbiome, dysbiosis and skin diseases

Skin Barrier Function: The Interplay of Physical, Chemical, and Immunologic Properties

The skin: an indispensable barrier

Skin Barrier Function and Microtopography in Patients with Atopic Dermatitis

Cytokine profile of the epidermis is region specific and may determine the characteristics of inflammation

Skin, gut, and lung barrier: Physiological interface and target of intervention for preventing and treating allergic diseases

Association between barrier impairment and skin microbiota in atopic dermatitis from a global perspective: Unmet needs and open questions

Skin Barriers in Dermal Drug Delivery: Which Barriers Have to Be Overcome and How Can We Measure Them?

Targeting the gut‐skin axis—Probiotics as new tools for skin disorder management?

T cell pathology in skin inflammation

[Protection of the Skin Barrier Function in Inflammatory Disease]

Filaggrin and beyond: New insights into the skin barrier in atopic dermatitis and allergic diseases, from genetics to therapeutic perspectives

Molecular Mechanism of Epidermal Barrier Dysfunction as Primary Abnormalities

Temporal and Spatial Variation of the Skin-Associated Bacteria from Healthy Participants and Atopic Dermatitis Patients

The skin microbiome: impact of modern environments on skin ecology, barrier integrity, and systemic immune programming

The microbiome of the human skin and its variability in psoriasis and atopic dermatitis

Skin immunity and its dysregulation in psoriasis.

Gut–Skin Axis: Current Knowledge of the Interrelationship between Microbial Dysbiosis and Skin Conditions

Bioactive lipids in the skin barrier mediate its functionality in health and disease